Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
  • A61K8/11—Encapsulated compositions
• • A—HUMAN NECESSITIES
  • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
  • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
  • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
  • A01N25/26—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
  • A01N25/28—Microcapsules or nanocapsules
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
  • A61K8/25—Silicon; Compounds thereof
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K8/00—Cosmetics or similar toiletry preparations
  • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
  • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
  • A61K8/73—Polysaccharides
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q13/00—Formulations or additives for perfume preparations
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
  • A61Q19/00—Preparations for care of the skin
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
  • B01J13/02—Making microcapsules or microballoons
  • B01J13/06—Making microcapsules or microballoons by phase separation
  • B01J13/14—Polymerisation; cross-linking
  • B01J13/18—In situ polymerisation with all reactants being present in the same phase
• • B—PERFORMING OPERATIONS; TRANSPORTING
  • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
  • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
  • B01J13/00—Colloid chemistry, e.g. the production of colloidal materials or their solutions, not otherwise provided for; Making microcapsules or microballoons
  • B01J13/02—Making microcapsules or microballoons
  • B01J13/20—After-treatment of capsule walls, e.g. hardening
  • B01J13/22—Coating
• • C—CHEMISTRY; METALLURGY
  • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
  • C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
  • C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
  • C09B67/0097—Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D17/00—Detergent materials or soaps characterised by their shape or physical properties
  • C11D17/0039—Coated compositions or coated components in the compositions, (micro)capsules
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/16—Organic compounds
  • C11D3/20—Organic compounds containing oxygen
  • C11D3/22—Carbohydrates or derivatives thereof
  • C11D3/222—Natural or synthetic polysaccharides, e.g. cellulose, starch, gum, alginic acid or cyclodextrin
• • C—CHEMISTRY; METALLURGY
  • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
  • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
  • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
  • C11D3/50—Perfumes
  • C11D3/502—Protected perfumes
  • C11D3/505—Protected perfumes encapsulated or adsorbed on a carrier, e.g. zeolite or clay
• • D—TEXTILES; PAPER
  • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
  • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
  • D06M13/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with non-macromolecular organic compounds; Such treatment combined with mechanical treatment
  • D06M13/005—Compositions containing perfumes; Compositions containing deodorants
• • D—TEXTILES; PAPER
  • D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
  • D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
  • D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
  • D06M23/12—Processes in which the treating agent is incorporated in microcapsules
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
  • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
  • A61K2800/41—Particular ingredients further characterized by their size
  • A61K2800/412—Microsized, i.e. having sizes between 0.1 and 100 microns

Definitions

• the present invention relates to microcapsule aqueous dispersions.
• microcapsules encapsulating fragrances and bioactive substances have been developed and used in a wide range of business fields such as cosmetics, pharmaceuticals, general household products, and printing.
• methods for producing such microcapsules include chemical methods such as suspension polymerization, miniemulsion polymerization, emulsion polymerization, precipitation polymerization, dispersion polymerization, interfacial polycondensation, and in-liquid curing; Physico-chemical methods such as method, phase inversion emulsification method and coacervation method; mechanical methods such as spray drying method and heteroaggregation method.
• Many methods for producing the microcapsules are obtained as an aqueous dispersion in which the microcapsules are dispersed in an aqueous medium. It is desirable to use the aqueous dispersion of microcapsules as it is. Therefore, various investigations have been made so far on aqueous dispersions of microcapsules.
• a fluid and stable silica capsule composition is composed of a silica capsule suspension and an adjuvant, and the adjuvant is vinylpyrrolidone/dimethylaminoethyl methacrylate.
• the use of cationic polymers such as copolymers is described.
• Patent Document 2 microcapsules dispersed in an aqueous phase for the purpose of increasing the dispersion stability of a microcapsule composition with a viscosity modifier, and a viscosity modifier.
• a microcapsule composition is described and the viscosity modifier is described to be an acrylate copolymer, a cationic acrylamide copolymer, or a polysaccharide.
• Japanese Patent Application Publication No. 2012-501849 discloses a silicate shell using an organofunctional silane as a colloidal silicate blocking agent for the purpose of improving the stability of an aqueous suspension of microcapsules having a silicate shell.
• the present invention relates to an aqueous microcapsule dispersion containing the following components (A) and (B).
• Component Polysaccharide containing a cation-modified branched chain structure
• the aqueous dispersion of microcapsules has a problem that the flowability is lowered depending on the difference in specific gravity between the microcapsules and the aqueous medium, the viscosity of the aqueous medium, and the particle size and shape of the microcapsules. For example, if the specific gravity of the microcapsules is relatively small with respect to the aqueous medium, creaming will occur over time and the fluidity will be lost, and if the specific gravity of the microcapsules is relatively high, the microcapsules will settle and flow over time. lose sex.
• an aqueous dispersion of microcapsules that suppresses the formation of microcapsule aggregates even when stored for a long period of time, suppresses a decrease in fluidity, and has excellent dispersion stability. Furthermore, from the viewpoint of controlling the sustained release of the organic compound encapsulated in the microcapsules, the microcapsules have a good particle size even after long-term storage of the aqueous dispersion of the microcapsules, and the particle size of the microcapsules There is a demand for an aqueous dispersion of microcapsules that has less variation in particle size and excellent uniformity in particle size.
• the present invention relates to an aqueous dispersion of microcapsules that has excellent dispersion stability even after long-term storage, microcapsules having a favorable particle size, little variation in particle size, and excellent uniformity in particle size. .
• an aqueous dispersion of microcapsules having a shell containing an inorganic substance as a component and a core containing one or more organic compounds inside the shell contains a multi-layer structure containing a cation-modified branched chain structure.
• the dispersion stability of the microcapsules in the aqueous dispersion is improved even after long-term storage, the microcapsules have a good particle size, and the particle size variation is small. Focusing on improving the uniformity of the diameter, the inventors found that an aqueous dispersion of microcapsules can be provided.
• the present invention relates to an aqueous microcapsule dispersion containing the following components (A) and (B).
• Component Polysaccharide containing a cation-modified branched chain structure
• the water dispersion of microcapsules is excellent in dispersion stability, the microcapsules have a favorable particle size, and there is little variation in particle size and excellent uniformity in particle size. liquid can be provided.
• microcapsule aqueous dispersion contains the following components (A) and (B).
• A) component microcapsules having a shell containing an inorganic substance as a constituent component and a core containing one or more organic compounds inside the shell
• B) component polysaccharide containing a cation-modified branched chain structure
• a polysaccharide containing a cation-modified branched chain structure is a polysaccharide having a cation-modified branched chain structure in which at least one of the components of the cation-modified polysaccharide is cation-modified.
• a polysaccharide containing a cation-modified branched chain structure includes a polysaccharide having a cation-modified branched chain structure and a polysaccharide having a cation-modified branched chain structure. It is a concept including mixtures containing polysaccharides having a cation-modified linear structure.
• a polysaccharide having a cation-modified branched chain structure is a modified polysaccharide in which a cationic group is introduced into the polysaccharide skeleton in which three or more of one or more monosaccharides are linked. , means that the structure of the modified polysaccharide is a branched chain structure due to having at least one monosaccharide molecule having three or more bonding sites with adjacent monosaccharide molecules.
• a polysaccharide having a cation-modified linear structure is a modified polysaccharide in which a cationic group is introduced into the polysaccharide skeleton in which three or more of one or more monosaccharides are linked.
• the structure of the modified polysaccharide is a linear structure by having two binding sites with adjacent monosaccharide molecules in one monosaccharide molecule.
• the cationic group refers to a cationic group or a group that can be ionized to become a cationic group, for example, a quaternary ammonium group or a group that can become a cationic group by adding protons.
• polysaccharide containing a cation-modified branched chain structure is also simply referred to as "cationized branched polysaccharide”.
• microcapsule aqueous dispersion of the present invention is obtained by dispersing microcapsules as component (A) in an aqueous medium.
• aqueous medium refers to a liquid containing at least water, preferably a medium in which water accounts for the largest proportion.
• Components other than water that the aqueous medium may contain include aliphatic alcohols having 1 to 4 carbon atoms; ketones having 3 to 8 carbon atoms; ethers such as ethyl ether and tetrahydrofuran; and esters such as methyl acetate. mentioned.
• the content of water in the aqueous medium is preferably 80% by mass or more from the viewpoint of improving the dispersion stability of the microcapsules, and from the viewpoint of improving the particle size uniformity of the microcapsules and improving the particle size uniformity. It is more preferably 90% by mass or more and 100% by mass or less, and still more preferably 100% by mass.
• water ion-exchanged water, deionized water, or distilled water is preferably used.
• "containing component (A) and component (B)" also means “comprising component (A) and component (B)".
• the microcapsules as component (A) in the aqueous dispersion may form flocs.
• the term “floc” means a state in which microcapsules dispersed in an aqueous dispersion form aggregates in the aqueous dispersion by standing or the like. In the present invention, even after the microcapsules form flocs in the water dispersion, the microcapsules can be re-dispersed in the water dispersion by stirring or shaking. From that point of view, "floc” here means a reversible phenomenon.
• the term “aggregation” as used herein means a state in which microcapsules dispersed in an aqueous dispersion form aggregates in the aqueous dispersion due to standing or the like. This aggregate cannot return to the original dispersed state of the microcapsules in the aqueous dispersion even if stirring or shaking is performed. In some cases, the aggregates can be re-dispersed by crushing, which disaggregates the aggregates by applying physical force to the aggregates. and From this point of view, "aggregation” in this specification means a phenomenon that is irreversible by dispersing means such as stirring or shaking.
• the terms “stirring” and “shaking” when redispersing the microcapsules refer to externally applying a physical force to the aqueous dispersion so as not to damage the microcapsules as much as possible, and dispersing the inside of the system. It means an operation to return to a uniformly dispersed state.
• a polysaccharide containing a cation-modified branched chain structure (cationized branched polysaccharide) has a plurality of hydroxy groups and cationic groups. Therefore, in the aqueous dispersion, while the hydroxy groups of the cationized branched polysaccharide are adsorbed to the microcapsule surface, the cationic groups of the cationized branched polysaccharide are positively charged on the microcapsule surface and electrostatic repulsion.
• the polymer chains of the cationized branched polysaccharide spread in an aqueous medium, and the steric repulsive force and electrostatic repulsive force act synergistically between the microcapsules to suppress the formation of microcapsule aggregates. is considered possible. Furthermore, in the present invention, since the cationized branched polysaccharide has a branched chain structure, a phenomenon in which one polymer chain simultaneously adsorbs to a plurality of microcapsule surfaces and aggregates the microcapsules, so-called cross-linking aggregation, is difficult to occur.
• the steric repulsive force and electrostatic repulsive force between the microcapsules act more effectively to suppress the formation of microcapsule aggregates, and as a result, the dispersion stability of the microcapsules is improved. It is considered that the particle size uniformity of the microcapsules is improved by improving the particle size of the microcapsules.
• the microcapsule aqueous dispersion of the present invention contains, as component (A), microcapsules having a shell containing an inorganic substance as a constituent component and a core containing one or more organic compounds inside the shell.
• the inorganic substance constituting the shell of the component (A) is preferably a metal oxide containing a metal element or a metalloid element, more preferably a sol-gel with a metal alkoxide [M(OR)x] as a shell precursor. It is an inorganic polymer formed by a reaction.
• M is a metal or metalloid element and R is a hydrocarbon radical.
• the inorganic substance has the viewpoint of improving the dispersion stability of the microcapsules, the viewpoint of improving the particle size of the microcapsules and improving the uniformity of the particle size, and the viewpoint of reducing the environmental load when released into the external environment.
• the component (A) is preferably a microcapsule (silica microcapsule) having a shell containing silica as a constituent and a core containing one or more organic compounds inside the shell (hereinafter referred to as "silica capsule ”).
• the alkoxysilane is preferably tetraalkoxysilane from the viewpoint of improving the dispersion stability of the microcapsules, improving the particle size of the microcapsules, and improving the uniformity of the particle size.
• the tetraalkoxysilane preferably has an alkoxy group having 1 to 4 carbon atoms, and is more preferably selected from tetramethoxysilane, tetraethoxysilane, and tetraisopropoxysilane. It is one or more, more preferably one or more selected from tetramethoxysilane and tetraethoxysilane, and even more preferably tetraethoxysilane.
• the organic compound contained in the core of component (A) is preferably perfume; perfume precursor; oil; antioxidant; antibacterial agent; One or more selected from dyes; pigments; silicones; solvents; More preferably one or more selected from fragrances, fragrance precursors, oils, antioxidants and solvents, still more preferably one or more selected from fragrances, fragrance precursors and oils, still more preferably fragrances and one or more selected from perfume precursors.
• the organic compounds can be appropriately combined according to the use of the microcapsules.
• perfume precursors include compounds that release perfume components in response to water, compounds that release perfume components in response to light, and the like.
• the compound that reacts with water to release a fragrance component include a silicate ester compound having an alkoxy component derived from a fragrance alcohol, a fatty acid ester compound having an alkoxy component derived from a fragrance alcohol, a carbonyl component derived from a fragrance aldehyde or a fragrance ketone, and an alcohol.
• fragrance aldehyde or a fragrance ketone an acetal compound or a hemiacetal compound obtained by reaction of a compound, a Schiff base compound obtained by reaction of a carbonyl component derived from a fragrance aldehyde or a fragrance ketone and a primary amine compound, a carbonyl component derived from a fragrance aldehyde or a fragrance ketone and a hydrazine compound; Hemiaminal compounds or hydrazone compounds obtained by the reaction of.
• Compounds that release fragrance components in response to light include 2-nitrobenzyl ether compounds having alkoxy components derived from fragrance alcohols, ⁇ -keto ester compounds having carbonyl components derived from fragrance aldehydes or fragrance ketones, and alkoxy compounds derived from fragrance alcohols. a coumaric acid ester compound having a These perfume precursors may be used as polymers, for example reaction products of some carboxyl groups of polyacrylic acid and perfume alcohols.
• the organic compound preferably has moderate hydrophobicity from the viewpoint of retention of the organic compound.
• the cLogP value which is the calculated value of the common logarithm "logP" of the partition coefficient P (n-octanol/water) between n-octanol and water.
• the cLogP value is "LogP (cLogP)" calculated by the method described in A. Leo Comprehensive Medicinal Chemistry, Vol.4 C. Hansch, PGSammens, JB Taylor and CARamsden, Eds., P.295, Pergamon Press, 1990. , cLogP values calculated by the program CLOGP v4.01.
• the cLogP value of the organic compound can be obtained by multiplying the cLogP value of each component by the volume ratio of each component and summing the results.
• the cLogP value of the organic compound is preferably 1 or more, more preferably 2 or more, still more preferably 3 or more, still more preferably 4 or more, and preferably 30 or less, more preferably 20 or less, and even more preferably 10 or less.
• the shell of the silica capsule surrounds the core, contains silica as a constituent, and preferably has an average thickness of 5 nm or more and 20 nm or less.
• the shell of the silica capsule from the viewpoint of improving the dispersion stability of the microcapsules, and from the viewpoint of retention of organic compounds, an inner shell containing silica, which is a hydrolytic polycondensate of alkoxysilane, as a constituent component; It is preferable that the multi-layered shell has an outer shell containing silica, which is a hydrolytic polycondensate of alkoxysilane, as a constituent component on the outside of the shell.
• a specific example of such a silica capsule is, for example, the silica capsule described in JP-A-2015-128762.
• the shell of the silica capsule is a multilayer shell having an inner shell and an outer shell
• the shell of the inner shell encloses the core, contains silica as a constituent, and preferably has an average thickness of 5 nm or more and 20 nm or less.
• the outer shell encloses the inner shell, contains silica as a constituent, and preferably has an average thickness of 10 nm or more and 100 nm or less.
• the average thickness of the silica capsule shell and the average thickness of the inner and outer shells of the silica capsule can be measured by observation with a transmission electron microscope (TEM).
• TEM transmission electron microscope
• the thickness of the shell or inner and outer shells is actually measured on a photograph under observation with a transmission electron microscope. This operation is performed by changing the field of view five times. From the data obtained, the average thickness distribution of the shell or inner and outer shells is determined.
• the standard magnification of the transmission electron microscope is from 10,000 times to 100,000 times, but it can be adjusted according to the size of the silica capsule.
• TEM transmission electron microscope
• JEM-2100 manufactured by JEOL Ltd.
• the (A) component can be appropriately synthesized.
• the silica capsule is preferably produced by a method including the following step I, for example.
• Step I An emulsified liquid obtained by emulsifying an aqueous phase component containing a cationic surfactant and an oil phase component containing an organic compound and a tetraalkoxysilane is subjected to a sol-gel reaction under acidic conditions to form a core and A step of forming a silica capsule having a shell comprising silica as a component, and obtaining an aqueous dispersion containing the silica capsule
• Cationic surfactants used in step I include alkylamine salts, alkyl quaternary ammonium salts and the like.
• the number of carbon atoms in the alkyl group of the alkylamine salt and the alkyl quaternary ammonium salt is preferably 10 or more and 22 or less.
• the content of the cationic surfactant in the aqueous phase component is preferably 0.05% by mass or more and 10% by mass or less from the viewpoint of dispersion stability of emulsified droplets.
• the amount of tetraalkoxysilane used in step I is preferably 10 parts by mass with respect to 100 parts by mass of the organic compound used in step I from the viewpoint of promoting the sol-gel reaction and forming a sufficiently dense shell.
• the amount is preferably 60 parts by mass or less.
• the amount of the oil phase component in the total amount of the emulsified liquid used in step I is preferably 5% by mass or more and 50% by mass or less from the viewpoint of production efficiency.
• the stirring means used for preparing the emulsified liquid is not particularly limited, but a homogenizer having a strong shearing force, a high-pressure disperser, an ultrasonic disperser, or the like can be used.
• the temperature at which the water phase component and the oil phase component are mixed and emulsified is preferably 5° C. or higher and 50° C. or lower from the viewpoint of production stability.
• the median diameter D 50 of the emulsified droplets in the emulsion in step I is preferably 0.1 ⁇ m or more from the viewpoint of reducing the specific surface area to the environment outside the silica capsule and increasing the retention of the organic compound. From the viewpoint of reducing the particle size and the physical strength of the silica capsule, it is preferably 50 ⁇ m or less.
• the median diameter D50 of emulsified droplets can be measured by the method described in Examples.
• the initial pH of the sol-gel reaction in step I is determined from the viewpoint of maintaining a balance between the hydrolysis reaction and the condensation reaction of tetraalkoxysilane, and from the viewpoint of suppressing the formation of a highly hydrophilic sol and promoting the progress of encapsulation. It is preferably 3.0 or more, and is preferably 4.5 or less from the viewpoint of suppressing simultaneous occurrence of silica shell formation and aggregation of emulsified droplets and obtaining a silica capsule having a dense shell. From the viewpoint of adjusting the initial pH to a desired level according to the strength of acidity or alkalinity of the oil phase component containing the organic compound, the pH of the emulsion may be adjusted using a pH adjuster.
• acidic pH adjusters include inorganic acids such as hydrochloric acid, nitric acid and sulfuric acid, organic acids such as acetic acid and citric acid, liquids obtained by adding cation exchange resins and the like to water, ethanol and the like, and preferably hydrochloric acid and sulfuric acid. , nitric acid, and citric acid.
• Alkaline pH adjusters include sodium hydroxide, sodium bicarbonate, potassium hydroxide, ammonium hydroxide, diethanolamine, triethanolamine, trishydroxymethylaminomethane and the like, preferably sodium hydroxide and ammonium hydroxide. One or more selected.
• the pH of the emulsified liquid may be below the desired value. In that case, it is preferable to adjust using the above-mentioned alkaline pH adjuster.
• the reaction temperature of the sol-gel reaction in step I can be any value as long as it is above the melting point and below the boiling point of water contained as the aqueous phase. From the viewpoint of controlling the balance and forming a dense shell, it is preferable to keep the temperature within a certain range.
• the range is preferably 5° C. or higher and 60° C. or lower, more preferably 10° C. or higher and 50° C. or lower.
• the reaction time of the sol-gel reaction in step I is preferably 0.5 hours or more and 50 hours or less, assuming that the reaction starts when the inside of the reaction system reaches a predetermined reaction temperature.
• silica capsule (1) an aqueous dispersion containing the silica capsule obtained in step I (hereinafter referred to as silica capsule (1))
• silica capsule (1) silica formed by adding tetraalkoxysilane as a silica precursor and carrying out a sol-gel reaction in two steps is included as a constituent component. That is, the silica capsule in this case is preferably produced by a method including steps 1 and 2 below.
• Step 1 An emulsion obtained by emulsifying an aqueous phase component containing a cationic surfactant and an oil phase component containing an organic compound and a tetraalkoxysilane is subjected to a sol-gel reaction under acidic conditions to form a core and , a step of forming a silica capsule (1) having a first shell containing silica as a constituent component, and obtaining an aqueous dispersion containing the silica capsule (1)
• Step 2 The silica capsule obtained in Step 1 ( A step of forming a silica capsule having a second shell surrounding the first shell by further adding a tetraalkoxysilane to the aqueous dispersion containing 1) and performing a sol-gel reaction.
• step 2 when performing steps 1 and 2, "enclose the first shell” means enclosing the first shell of the silica capsule (1) formed in step 1. and enclosing the silica capsule (1).
• a shell is further formed on the silica capsule formed in step 1, and the silica capsule obtained in step 2 becomes a silica capsule with an increased shell thickness as a whole, and the shell formed in step 1. is the inner shell and the shell formed in step 2 is the outer shell.
• step 1 the same operation as in step I described above can be performed.
• the amount of tetraalkoxysilane used in step 2 is preferably 7 parts by mass or more with respect to 100 parts by mass of the organic compound used in step 1, from the viewpoint of forming the second shell enclosing the first shell.
• the viewpoint of suppressing the generation of silica sol dispersed in the aqueous phase and improving the dispersion stability of the silica capsules preferably It is 200 parts by mass or less.
• the total amount of tetraalkoxysilanes used when steps 1 and 2 are included, that is, the total amount of tetraalkoxysilanes used in steps 1 and 2 is preferably 30 parts per 100 parts by mass of the organic compound used in step 1. 1 part by mass or more, and preferably 250 parts by mass or less.
• the median diameter D50 of the microcapsules of component (A) is preferably 100 ⁇ m or less, more preferably 75 ⁇ m or less, and even more preferably 50 ⁇ m from the viewpoint of improving the dispersion stability of the microcapsules based on the Stokes formula. Below, more preferably 30 ⁇ m or less, still more preferably 10 ⁇ m or less.
• the median diameter D50 of component (A) can be measured by the method described in Examples.
• the specific gravity difference between the component and the aqueous medium improves the dispersion stability of the microcapsules, suppresses the deterioration of the fluidity of the microcapsule aqueous dispersion over time, and improves the particle size of the microcapsules. and, from the viewpoint of improving particle size uniformity, it is preferably less than 0.30, more preferably less than 0.20, even more preferably less than 0.15, even more preferably less than 0.10, still more preferably It is preferably less than 0.05, even more preferably less than 0.01 and even more preferably no specific gravity difference.
• the specific gravity of the component (A) is determined by the specific gravity of the shell and the core that constitute the component (A) and the mass ratio of the shell and the core.
• the microcapsule aqueous dispersion of the present invention contains a cation as the component (B).
• a cation as the component (B).
• cationized branched polysaccharides may be used singly or in combination of two or more.
• the cationic charge density of the component (B) is preferably 0.3 meq/g from the viewpoint of improving the dispersion stability of the microcapsules, improving the particle size of the microcapsules, and improving the uniformity of the particle size. Above, more preferably 0.5 meq/g or more, still more preferably 0.7 meq/g or more, and preferably 3.0 meq/g or less, more preferably 2.5 meq/g or less, still more preferably It is 2.0 meq/g or less, more preferably 1.7 meq/g or less, and even more preferably 1.5 meq/g or less.
• the cationic charge density can be calculated by the following formula (1).
• Cationic charge density (meq/g) nitrogen content (% by mass) ⁇ 14 x 10 (1)
• the nitrogen content in component (B) can be measured by the Kjeldahl method.
• the cationic charge density is determined by calculating the weighted average from the cationic charge densities and blending amounts of the respective cationized branched polysaccharides.
• the polymer backbone of component (B) is preferably a polysaccharide containing linked hexose residues, wherein at least one of the hexose residues constituting the polysaccharide is 1, as a binding site for adjacent hexose residues.
• a polysaccharide having a binding site more preferably a hexose residue linked by a 1,4 bond as a main chain, and a branched chain of hexose residues branched by a 1,6-position bond to the hexose residue of the main chain
• the number of hexose residues per branched chain may be one, or two or more.
• the hexose constituting the polymer skeleton of component (B) one or more selected from mannose, galactose, glucose, and xylose are preferably used.
• a main chain is composed of mannose residues linked by ⁇ -1,4 bonds, and galactose residues branched from the mannose residues of the main chain by ⁇ -1,6 bonds.
• a polysaccharide having a branched chain, and having a main chain of glucose residues linked by ⁇ -1,4 bonds, and a branched chain of glucose residues branched by ⁇ -1,6 bonds in the main chain of glucose residues One or more selected from polysaccharides are preferred.
• component (B) is a mixture containing a cation-modified polysaccharide having a branched chain structure and a cation-modified polysaccharide having a linear structure, it is included as a constituent component of the component (B). It is sufficient that the polysaccharide having a cation-modified branched chain structure to be used has the aforementioned polymer backbone.
• component (B) examples include cationized galactomannans such as cationized guar gum, cationized tara gum, cationized fenugreek gum and cationized locust bean gum; cationized starch; tamarind seed gum and the like.
• the component (B) has the viewpoint of improving the dispersion stability of the microcapsules, making the particle size of the microcapsules favorable, improving the uniformity of the particle size, and the dispersion stability of the microcapsules even in a small amount. It is preferably one or more selected from cationized galactomannan and cationized starch, and more preferably cationized galactomannan, from the viewpoint of enhancing the properties.
• a cationized galactomannan is a modified polysaccharide obtained by introducing a quaternary ammonium group into a galactomannan having a main chain of mannose as a constituent unit and a side chain of galactose as a constituent unit.
• Galactomannans can be obtained, for example, from the endosperm of legume seeds. Since the cationized galactomannan has a plurality of hydroxy groups and cationic groups and has a branched chain structure, the steric repulsion and electrostatic repulsion between the microcapsules described above are more effective.
• the component (B) is more preferably one or more selected from cationized guar gum, cationized tara gum, cationized fenugreek gum, and cationized locust bean gum, and even more preferably cationized guar gum and cationic and more preferably cationized guar gum, still more preferably O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride (display name: guar hydroxypropyl trimonium chloride) and a hydroxypropyl derivative of O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride (display name: hydroxypropyl guar hydroxypropyltrimonium chloride).
• Examples of commercially available component (B) include cationized guar gums such as the Jaguar series manufactured by Solvay, the Labor gum series manufactured by DSP Gokyo Food &Chemical; cationized tara gum such as ", cationized locust bean gum such as "Catinal CLB-100” manufactured by Toho Chemical Industry Co., Ltd.; cationized starch such as EXCELL series manufactured by Niommen Kagaku Co., Ltd.;
• microcapsule aqueous dispersion of the present invention may contain other components other than components (A) and (B), if necessary.
• Other ingredients include pH adjusters, pigments, preservatives, antioxidants, UV absorbers, shell surface modifiers, inorganic salts, thickeners, deposition aids, rheology modifiers and the like.
• the aqueous microcapsule dispersion of the present invention may optionally contain a fabric softener, a fabric freshening agent, and a fabric softener other than the components (A) and (B).
• a fabric softener such as a fabric softener, a fabric freshening agent, and a fabric softener other than the components (A) and (B).
• Fabric strengthening agents, enzymes, builders, hair conditioning agents, skin conditioning agents, fragrances, clays, zeolites, silicones, etc. may be pre-incorporated.
• the method for producing the aqueous microcapsule dispersion of the present invention is not particularly limited.
• it can be produced by a method including a step of mixing components (A) and (B), which have been produced in advance by a known method, and, if necessary, other components described above, using a known stirring device or the like.
• the method for producing a microcapsule aqueous dispersion of the present invention from the viewpoint of ease of production, preferably comprises an aqueous dispersion containing component (A), component (B), and, if necessary, the other components described above. and mixing.
• the method for producing the aqueous microcapsule dispersion of the present invention comprises an aqueous dispersion containing silica capsules as the component (A), the component (B), and, if necessary, A preferred method comprises the step of mixing with the other ingredients mentioned above.
• An aqueous dispersion containing silica capsules can be obtained by the method described above.
• the method of mixing the aqueous dispersion containing the component (A) and the component (B) is not particularly limited from the viewpoint of ease of production. It is preferred to include the step of adding and mixing the ingredients.
• the component (B) may be used as an aqueous solution from the viewpoint of ease of blending.
• the aqueous solution of component (B) may be prepared by dissolving component (B) in water after adjusting the pH according to the solubility of component (B) in water.
• the mixing temperature of the water dispersion containing the component (A), the component (B), and the other components described above as necessary is preferably 15° C. or higher, more preferably 15° C. or higher, from the viewpoint of the dispersion stability of the microcapsules. 20° C. or higher, and preferably 35° C. or lower, more preferably 30° C. or lower.
• a well-known stirring apparatus etc. can be used for mixing of each component.
• composition of microcapsule aqueous dispersion of the present invention is determined from the viewpoint of lowering the viscosity of the aqueous dispersion and improving the handleability, improving the dispersion stability of the microcapsules, and improving the microcapsule dispersion stability. From the viewpoint of improving the particle size of the capsule and improving the particle size uniformity, it is preferably 50% by mass or less, more preferably 40% by mass or less, even more preferably 30% by mass or less, and even more preferably 25% by mass.
• aqueous dispersion preferably 3% by mass or more, more preferably 5% by mass or more, even more preferably 10% by mass or more, and more More preferably 15% by mass or more, still more preferably 18% by mass or more, and even more preferably 20% by mass or more.
• the content or blending amount of component (B) in the microcapsule aqueous dispersion of the present invention improves the dispersion stability of the microcapsules, improves the particle size of the microcapsules, and improves the particle size uniformity.
• the particle size of the microcapsules is improved, and the particle size uniformity and from the viewpoint of lowering the viscosity of the aqueous dispersion and improving the handleability, it is preferably 1.5% by mass or less, more preferably 1% by mass or less, still more preferably 0.7% by mass or less, and more More preferably 0.5% by mass or less, still more preferably 0.3% by mass or less, still more preferably 0.2% by mass or less, still more preferably 0.15% by mass or less, still more preferably 0.13% by mass % by mass or less, more preferably 0.1% by mass
• the content or blending amount of component (B) with respect to 100 parts by mass of component (A) in the microcapsule aqueous dispersion of the present invention is from the viewpoint of the dispersion stability of the microcapsules and the particle size of the microcapsules. , from the viewpoint of improving particle size uniformity, preferably 0.03 parts by mass or more, more preferably 0.05 parts by mass or more, still more preferably 0.1 parts by mass or more, and even more preferably 0.15 parts by mass or more , It is more preferably 0.2 parts by mass or more, and from the viewpoint of suppressing the formation of microcapsule aggregates in the aqueous dispersion and improving the dispersion stability of the microcapsules, the particle size of the microcapsules is good.
• the aqueous dispersion From the viewpoint of improving the uniformity of the particle size, and from the viewpoint of lowering the viscosity of the aqueous dispersion and improving the handleability, it is preferably 3 parts by mass or less, more preferably 2 parts by mass or less, and still more preferably 1 part by mass. Part by mass or less, more preferably 0.8 part by mass or less, and even more preferably 0.6 part by mass or less.
• the content or blending amount of water in the microcapsule aqueous dispersion of the present invention is, from the viewpoint of the dispersion stability of the microcapsules, and from the viewpoint of improving the particle size uniformity of the microcapsules by improving the particle size of the microcapsules, Preferably 50% by mass or more, more preferably 60% by mass or more, still more preferably 70% by mass or more, still more preferably 75% by mass or more, and preferably 97% by mass or less, more preferably 95% by mass or less , more preferably 90% by mass or less, still more preferably 85% by mass or less.
• the viscosity of the aqueous microcapsule dispersion of the present invention at 25° C. is preferably 1 mPa ⁇ s or more, more preferably 3 mPa ⁇ s or more, still more preferably 5 mPa ⁇ s or more, still more preferably 10 mPa ⁇ s or more, and , preferably 4,000 mPa s or less, more preferably 2,000 mPa s or less, still more preferably 1,000 mPa s or less, even more preferably 500 mPa s or less, still more preferably 100 mPa s or less, still more It is preferably 50 mPa ⁇ s or less, more preferably 30 mPa ⁇ s or less, and still more preferably 20 mPa ⁇ s or less.
• the viscosity at 25 ° C. of the microcapsule aqueous dispersion of the present invention was measured using a Brookfield viscometer (model: TVB-10, manufactured by Toki Sangyo Co., Ltd.) as described in the Examples, with a spindle of M3 or M4. It can be measured at a rotation speed of 60 rpm or 6 rpm and a measurement temperature of 25°C.
• microcapsule aqueous dispersion of the present invention has excellent dispersion stability of microcapsules, good microcapsule particle size, excellent particle size uniformity, and excellent handleability, and is therefore suitable for various applications.
• Applications include cosmetic products such as emulsions, lotions, lotions, serums, creams, gel preparations, hair treatment agents, and quasi-drugs; fiber treatment agents such as detergents, softeners, and anti-wrinkle sprays; Sanitary goods such as paper diapers; various uses such as fragrances;
• the microcapsule aqueous dispersion of the present invention can be used by containing or blending in liquid compositions such as detergent compositions, fiber treatment compositions, cosmetic compositions, fragrance compositions, and deodorant compositions.
• liquid compositions such as detergent compositions, fiber treatment compositions, cosmetic compositions, fragrance compositions, and deodorant compositions.
• the composition is preferably one or more selected from detergent compositions such as powder detergent compositions and liquid detergent compositions; fiber treatment compositions such as softener compositions; It is a fiber treatment composition, more preferably a softener composition.
• the present invention further discloses the following microcapsule aqueous dispersion and a method for producing the microcapsule aqueous dispersion.
• Component (B) preferably has a cationic charge density of 0.3 meq/g or more, more preferably 0.5 meq/g or more, still more preferably 0.7 meq/g or more. 0 meq/g or less, more preferably 2.5 meq/g or less, still more preferably 2.0 meq/g or less, even more preferably 1.7 meq/g or less, still more preferably 1.5 meq/g or less , the microcapsule aqueous dispersion according to ⁇ 1>.
• Component (B) is preferably one or more selected from cationized galactomannan and cationized starch, more preferably cationized galactomannan, still more preferably cationized guar gum, and even more preferably is O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride (display name: guar hydroxypropyltrimonium chloride) and O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride
• the inorganic substance constituting the shell of component (A) is preferably a metal oxide containing a metal element or a metalloid element, and more preferably a metal alkoxide [M(OR)x] as a shell precursor.
• An inorganic polymer formed by a sol-gel reaction more preferably an inorganic polymer formed by a sol-gel reaction using one or more metal alkoxides selected from silicon, aluminum, and titanium as a shell precursor.
• ⁇ 5> The aqueous microcapsule dispersion according to ⁇ 4>, wherein the alkoxysilane is preferably tetraalkoxysilane.
• ⁇ 6> Any of the above ⁇ 1> to ⁇ 3>, wherein the component (A) is a microcapsule having a shell containing silica as a constituent component and a core containing one or more organic compounds inside the shell.
• the shell includes an inner shell containing silica, which is a hydrolytic polycondensate of alkoxysilane, as a constituent component, and an outer shell further containing silica, which is a hydrolytic polycondensate of alkoxysilane, as a constituent component.
• the organic compound is preferably a perfume; a perfume precursor; an oil; an antioxidant; an antibacterial agent; solvent; and one or more selected from oil-soluble polymers, more preferably one or more selected from fragrances, fragrance precursors, oils, antioxidants, antibacterial agents, fertilizers, surface modifiers, and solvents, still more preferably One or more selected from fragrances, fragrance precursors, oils, antioxidants and solvents, more preferably one or more selected from fragrances, fragrance precursors and oils, still more preferably selected from fragrances and fragrance precursors
• the microcapsule aqueous dispersion according to any one of ⁇ 1> to ⁇ 7>, which is one or more kinds.
• the cLogP value of the organic compound is preferably 1 or more, more preferably 2 or more, still more preferably 3 or more, still more preferably 4 or more, and preferably 30 or less, more preferably 20 or less,
• the median diameter D 50 of the microcapsules of component (A) is preferably 100 ⁇ m or less, more preferably 75 ⁇ m or less, even more preferably 50 ⁇ m or less, even more preferably 30 ⁇ m or less, and even more preferably 10 ⁇ m or less, It is preferably 0.01 ⁇ m or more, more preferably 0.05 ⁇ m or more, still more preferably 0.07 ⁇ m or more, still more preferably 0.1 ⁇ m or more, still more preferably 0.5 ⁇ m or more, and even more preferably 1 ⁇ m or more.
• the microcapsule aqueous dispersion according to any one of ⁇ 1> to ⁇ 9>.
• the cationic charge density of component (B) is preferably 0.3 meq/g or more, more preferably 0.5 meq/g or more, still more preferably 0.7 meq/g or more, and preferably 3.0 meq/g or less, more preferably 2.5 meq/g or less, still more preferably 2.0 meq/g or less, even more preferably 1.7 meq/g or less, still more preferably 1.5 meq/g or less
• Component (B) is preferably a cationized galactomannan, more preferably one or more selected from cationized guar gum, cationized tara gum, cationized fenugreek gum, and cationized locust bean gum, and further Preferably one or more selected from cationized guar gum and cationized tara gum, more preferably cationized guar gum, and even more preferably chlorinated O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum (labeled name: guar hydroxypropyltrimonium chloride) and a hydroxypropyl derivative of O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride (labeled name: hydroxypropyl guar hydroxypropyltrimonium chloride), The aqueous microcapsule dispersion according to ⁇ 11> or ⁇ 12>.
• the content or amount of component (A) in the microcapsule aqueous dispersion is preferably 50% by mass or less, more preferably 40% by mass or less, even more preferably 30% by mass or less, and even more preferably 25% by mass. % by mass or less, and preferably 3% by mass or more, more preferably 5% by mass or more, even more preferably 10% by mass or more, even more preferably 15% by mass or more, even more preferably 18% by mass or more, and more
• the content or amount of component (B) in the microcapsule aqueous dispersion is preferably 0.001% by mass or more, more preferably 0.005% by mass or more, and still more preferably 0.01% by mass or more , more preferably 0.03% by mass or more, still more preferably 0.05% by mass or more, and preferably 1.5% by mass or less, more preferably 1% by mass or less, and even more preferably 0.7% by mass.
• aqueous microcapsule dispersion according to any one of ⁇ 1> to ⁇ 14>, which is preferably 0.13% by mass or less, more preferably 0.1% by mass or less.
• the content or blending amount of component (B) with respect to 100 parts by mass of component (A) in the microcapsule aqueous dispersion is preferably 0.03 parts by mass or more, more preferably 0.05 parts by mass or more, and further preferably 0.1 parts by mass or more, more preferably 0.15 parts by mass or more, still more preferably 0.2 parts by mass or more, and preferably 3 parts by mass or less, more preferably 2 parts by mass or less, More preferably 1 part by mass or less, still more preferably 0.8 parts by mass or less, still more preferably 0.6 parts by mass or less, the microcapsule water dispersion according to any one of ⁇ 1> to ⁇ 15> liquid.
• model perfume A volume average cLogP: 3.8, specific gravity: 0.88
• the volume average cLogP value of the model perfume was calculated as the sum of the cLogP values of all perfume components contained in the model perfume multiplied by the volume ratio in the model perfume.
• Synthesis of component (A) Synthesis example 1 (Step 1) 3.00 g of Cortamine 60W (trade name, manufactured by Kao Corporation, cetyltrimethylammonium chloride, effective content: 30% by mass) was diluted with 747.00 g of deionized water to obtain an aqueous phase component.
• An oil phase component prepared by mixing 200.70 g of model perfume A and 50.08 g of tetraethoxysilane (hereinafter also referred to as “TEOS”) was added to the water phase component, and the mixture was heated at room temperature (about 25°C).
• the mixture was emulsified for 15 minutes using a homomixer (manufactured by HsiangTai, model: HM-310) set at 8,500 rpm for 15 minutes to obtain an emulsion.
• the median diameter D50 of the emulsified droplets at this time was 1.1 ⁇ m.
• it was transferred to a separable flask equipped with a stirring blade and a cooler, and the liquid temperature was kept at 30°C.
• the mixture was stirred at 200 rpm for 24 hours to obtain an aqueous dispersion containing silica capsules having a core composed of model perfume A and a first shell.
• Step 2 Next, 32.8 g of TEOS was added dropwise to 973.24 g of the aqueous dispersion obtained in step 1 over 420 minutes. After the dropwise addition, the mixture was further stirred for 17 hours to form a second shell that encloses the first shell, and an inner shell containing silica, which is a hydrolytic polycondensate of alkoxysilane, as a constituent component, and an alkoxy further outside the inner shell.
• silica which is a hydrolytic polycondensate of alkoxysilane, as a constituent component, and an alkoxy further outside the inner shell.
• silica capsules (A-1) An aqueous dispersion containing 21.7% by mass of silica capsules (A-1) in which model perfume A is encapsulated in a multi-layered shell having an outer shell containing silica, which is a hydrolytic polycondensate of silane, as a constituent component is obtained.
• the median diameter D 50 of silica capsule (A-1) was 2.2 ⁇ m.
• the content of silica capsules (A-1) in the aqueous dispersion is a calculated value from the compounding composition when synthesizing the silica capsules.
• Examples 1-2 and Comparative Examples 1-3 The aqueous dispersion containing the component (A) obtained in Synthesis Example 1 and the component (B) are was mixed at room temperature (about 25° C.) to prepare an aqueous microcapsule dispersion.
• the aqueous solution of the component (B) was prepared by dissolving the powder of the component (B) in ion-exchanged water so as to obtain a predetermined concentration, if necessary.
• the aqueous solution of component (B) was adjusted to pH 4-5 using a 1% by mass sulfuric acid aqueous solution.
• Comparative Example 1 the aqueous dispersion containing the silica capsules (A-1) obtained in Synthesis Example 1 was used as it was for evaluation of dispersion stability without adding the component (B).
• Hydroxypropyl guar Hydroxypropyltrimonium chloride Jaguar C-162 (cationized guar gum (hydroxypropyl derivative of O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride), cationic charge density 0.93 meq/g , manufactured by Solvay, appearance: powder)
• Guar Hydroxypropyltrimonium Chloride Jaguar C-17K (cationized guar gum (O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride), cationic charge density 1.07-1.50 meq/g, Solvay company, appearance: powder) Hydroxyethyl cellulose: Natrosol 250HHR PC (manufactured by Ashland, appearance: powder) Dimethyldiallylammonium chloride/acrylamide copolymer: Marquat 550 (effective content 9%) (
• microcapsule aqueous dispersions obtained in Examples 1 and 2 can be returned to the original dispersed state by stirring or shaking even after storage, and the visual observation after the stirring or shaking Observation showed no decrease in fluidity and no aggregation, so it is presumed to be microcapsule flocs.
• Examples 3-5 and Comparative Example 4 The aqueous dispersion containing the (A) component obtained in Synthesis Example 1 and the (B) component so that the contents of the (A) component and the (B) component in the aqueous dispersion are shown in Table 3 below. was mixed at room temperature (about 25° C.) to prepare an aqueous microcapsule dispersion.
• the aqueous solution of the component (B) was prepared by dissolving the powder of the component (B) in ion-exchanged water so as to obtain a predetermined concentration, if necessary.
• the aqueous solution of component (B) was adjusted to pH 4-5 using a 1% by mass sulfuric acid aqueous solution.
• Hydroxypropyl guar Hydroxypropyltrimonium chloride Jaguar C-162 (cationized guar gum (hydroxypropyl derivative of O-[2-hydroxy-3-(trimethylammonio)propyl]guar gum chloride), cationic charge density 0.93 meq/g , manufactured by Solvay, appearance: powder)
• Cationized tara gum Catinal CTR-100 (manufactured by Toho Chemical Industry Co., Ltd., appearance: powder)
• Cationic starch EXCELL DH (manufactured by Nippon Starch Chemical Co., Ltd., appearance: powder)
• Cationized HEC Poise C-60H (polyquaternium-10, O-[2-hydroxy-3-(trimethylammonio)propyl]hydroxyethyl cellulose chloride, cationic charge density 1.1 to 1.8 meq / g, manufactured by Kao Corporation
• Viscosity of microcapsule aqueous dispersion after storage After the microcapsule aqueous dispersions obtained in Examples 2 to 5 and Comparative Example 4 were stored at room temperature (about 25°C) for 14 days, the viscosity of the microcapsule aqueous dispersion after storage at 25°C was B. Using a type viscometer (model: TVB-10, manufactured by Toki Sangyo Co., Ltd.), the spindle was M3 or M4, the rotational speed was 60 rpm or 6 rpm, and the measurement temperature was 25°C. Table 3 shows the results.
• the aqueous microcapsule dispersions of Examples are excellent in dispersion stability, and the particle size of the microcapsules and the viscosity of the aqueous microcapsule dispersions are good even after storage.
• the microcapsule aqueous dispersions of Examples have smaller coefficients of variation CV than those of Comparative Examples, it can be seen that the dispersion of particle diameters is small and the uniformity of particle diameters is excellent.
• the microcapsule aqueous dispersions of Examples contain a cationized branched polysaccharide containing a branched chain structure as the component (B), cross-linking aggregation is unlikely to occur, suppressing the formation of aggregates of microcapsules. As a result, it is presumed that the particle size uniformity is excellent even after storage.
• the structure of the cationized polysaccharide contained in the microcapsule aqueous dispersion of the comparative example is a linear structure, cross-linkage aggregation easily occurs, and the formation of microcapsule aggregates cannot be suppressed, resulting in poor particle size uniformity. presumed to be inferior. Therefore, according to the present invention, the dispersion stability of microcapsules in an aqueous dispersion can be improved, the particle size of microcapsules can be improved, and the uniformity of particle size can be improved.
• the microcapsule aqueous dispersion of the present invention can be stored in a state in which the dispersion stability of the microcapsules is well maintained, and the microcapsules have a good particle size even after long-term storage, and , excellent particle size uniformity of microcapsules. Therefore, the aqueous microcapsule dispersion of the present invention is used to impart various functions such as fragrances to various products such as laundry products, personal care products, cosmetics, household liquid products, etc., gelation and formation of aggregates. It is easy to handle without thickening due to thickening, and can be widely used.

Landscapes

• Life Sciences & Earth Sciences (AREA)
• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• General Health & Medical Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Organic Chemistry (AREA)
• Engineering & Computer Science (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Epidemiology (AREA)
• Birds (AREA)
• Wood Science & Technology (AREA)
• Oil, Petroleum & Natural Gas (AREA)
• Dispersion Chemistry (AREA)
• Textile Engineering (AREA)
• Agronomy & Crop Science (AREA)
• Environmental Sciences (AREA)
• Zoology (AREA)
• Dentistry (AREA)
• Toxicology (AREA)
• Plant Pathology (AREA)
• Molecular Biology (AREA)
• Emergency Medicine (AREA)
• Pest Control & Pesticides (AREA)
• Dermatology (AREA)
• Inorganic Chemistry (AREA)
• Manufacturing Of Micro-Capsules (AREA)
• Cosmetics (AREA)

Priority Applications (3)

Applications Claiming Priority (2)

Publications (1)

Family

ID=84691825

Family Applications (1)

Country Status (5)

Cited By (1)

Families Citing this family (1)

Citations (6)

Family Cites Families (2)

• 2022
  • 2022-06-29 US US18/573,452 patent/US20240293295A1/en active Pending
  • 2022-06-29 JP JP2022105138A patent/JP7658679B2/ja active Active
  • 2022-06-29 CN CN202280046192.2A patent/CN117580637A/zh active Pending
  • 2022-06-29 EP EP22833245.8A patent/EP4364813A4/en active Pending
  • 2022-06-29 WO PCT/JP2022/026083 patent/WO2023277099A1/ja not_active Ceased

Patent Citations (7)

Non-Patent Citations (2)

Also Published As

Similar Documents

Legal Events